An International Prognostic Scoring System (IPSS) for Waldenstrom's Macroglobulinemia was reported by Morel et al.
Parameters:
(1) age in years
(2) hemoglobin in g/dL
(3) platelet count per microliter
(4) beta-microglobulin
(5) serum monoclonal IgM protein
Parameter |
Finding |
Points |
---|---|---|
age in years |
<= 65 years of age |
0 |
|
> 65 years |
1 |
hemoglobin |
> 11.5 g/dL |
0 |
|
<= 11.5 g/dL |
1 |
platelet count |
> 100,000 per µL |
0 |
|
<= 100,000 per µL |
1 |
beta-microglobulin |
<= 3 mg/L |
0 |
|
> 3 mg/L |
1 |
serum monoclonal IgM protein |
<= 7 g/dL |
0 |
|
> 7 g/dL |
1 |
IPSS =
= SUM(points for all 5 parameters)
Interpretation:
• minimum IPSS: 0
• maximum IPSS: 5
• The higher the score the worse the prognosis.
IPSS and/or Age |
Risk Group |
5-Year Survival |
---|---|---|
IPSS <= 1 and age <= 65 years |
low |
87% |
IPSS <=1 and age > 65 years |
intermediate |
68% |
IPSS =2 |
intermediate |
68% |
IPSS>= 3 |
high |
36% |
Purpose: To evaluate a patient with Waldenstrom's macroglobulinemia using the Internatiaonal Prognostic Scoring System (IPSS).
Specialty: Hematology Oncology
Objective: severity, prognosis, stage
ICD-10: C88,